Body mass index and risk of progression from monoclonal gammopathy of undetermined significance to multiple myeloma: Results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

Detalles Bibliográficos
Autores principales: Chang, Vicky C., Khan, Ali A., Huang, Wen-Yi, Katki, Hormuzd A., Purdue, Mark P., Landgren, Ola, Hofmann, Jonathan N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975932/
https://www.ncbi.nlm.nih.gov/pubmed/35365600
http://dx.doi.org/10.1038/s41408-022-00642-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975932/
https://www.ncbi.nlm.nih.gov/pubmed/35365600
http://dx.doi.org/10.1038/s41408-022-00642-4

Ejemplares similares